Australia’s COVID-19 vaccination rollout program has been highly successful, with over 75 per cent of the population aged 16 and over having now completed their primary two-dose course of vaccination. As the Government works to complete the remainder of the primary vaccination rollout, work is well under way to prepare for the next phase of the vaccination program, which will be to offer the eligible population with a booster vaccination.
To provide even greater protection against COVID-19, every adult living in Australia will be eligible for their booster vaccination from six months after they completed their primary two-dose course.
The decision to provide the booster vaccination has been based on the latest advice received from the vaccine experts on the Australian Technical Advisory Group on Immunisation (ATAGI). The booster vaccination is not mandatory, and the primary two-dose vaccination course provides a high level of protection against the worst effects of COVID-19. However, ATAGI recommends the additional vaccination to provide the maximum protection available against COVID-19.
The Government has accepted ATAGI’s advice that the Pfizer vaccine be recommended for the booster dose, irrespective of the primary COVID-19 vaccine used. Australia’s medicines regulator, the Therapeutic Goods Administration, has approved the use of Pfizer vaccine for booster doses for people aged 18 and over.
Although not preferred, AstraZeneca can also be used as a booster dose in the following situations:
- for individuals who have received AstraZeneca for their first two doses if there are no contraindications or precautions for use,
- if a significant adverse reaction has occurred after a previous mRNA vaccine dose which contraindicates further doses of mRNA vaccine (e.g., anaphylaxis, myocarditis).
Boosters are immediately available to anyone aged 18 and over who had the second dose of their primary course six months or more ago.
To book your booster vaccination today, use the blow link and select the option for “Covid-19 Vaccine Dose 3 – Pfizer”.